Megan Roy is a nurse navigator for lung cancer patients at the Abramson Cancer Center. To learn more about her role, check out our interview with Megan.

Before his passing in November 2017, Jason Taylor wrote about his glioblastoma diagnosis and reflected on his cancer journey. A few years after his death, his wife, Alicia wrote about her own experience on caring for a loved one with cancer and moving forward after loss. Read their heartfelt words to learn more about their story.

Dahlia Sataloff, MD, FACS, is a Professor of Clinical Surgery and the Chair of Surgery at Pennsylvania Hospital. To learn more about her work, career and motivations, read our interview with Dr. Sataloff.

In 2017, the FDA approved the first cellular therapy for cancer, a living drug called Kymriah, developed at Penn by Dr. Carl June. Learn more about the significance of this new method of therapy and other revolutionary research being conducted at Penn.

Patricia Gambino, MSN, RN is a nurse navigator for GI oncology patients at Abramson Cancer Center. To learn more about her role as a nurse navigator, check out our interview with Patricia.

Abramson Cancer Center's Pancreatic Research Center, led by Dr. Ben Stranger, is revolutionizing the way this disease is treated. Learn more about pancreatic cancer clinical trials at Penn and why there is now hope for all stages.

Dr. Aggarwal and the rest of the team at Penn are transforming the way lung cancer is treated. Learn more about their research and how new drugs are helping patients.

It’s the leading cause of death in women and on the rise among women who have never smoked. But there’s still plenty that women can do to get ahead of lung cancer.

Check out our interview with radiation oncologist Abigail Berman, MD, MSCE to learn more about her research, practice and experience at Penn.

Andy Sealy, a metastatic breast cancer patient at Penn, discusses some positive and negative experiences she's had throughout her journey and offers advice for those who may know someone diagnosed with metastatic cancer.